Breast Cancer-Specific Mortality Pattern and Its Changing Feature According to Estrogen Receptor Status in Two Time Periods

about

Breast Cancer-Specific Mortality Pattern and Its Changing Feature According to Estrogen Receptor Status in Two Time Periods

Item

http://www.wikidata.org/entity/Q36051600

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Breast Cancer-Specific Mortali ...... tor Status in Two Time Periods

@ast

Breast Cancer-Specific Mortali ...... tor Status in Two Time Periods

@en

type

Item

label

Breast Cancer-Specific Mortali ...... tor Status in Two Time Periods

@ast

Breast Cancer-Specific Mortali ...... tor Status in Two Time Periods

@en

prefLabel

Breast Cancer-Specific Mortali ...... tor Status in Two Time Periods

@ast

Breast Cancer-Specific Mortali ...... tor Status in Two Time Periods

@en

P1476

Breast Cancer-Specific Mortali ...... tor Status in Two Time Periods

@en

P2093

Junjie Li

http://www.w3.org/2001/XMLSchema#string

Yirong Liu

http://www.w3.org/2001/XMLSchema#string

Yizhou Jiang

http://www.w3.org/2001/XMLSchema#string

Zhimin Shao

http://www.w3.org/2001/XMLSchema#string

P2860

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Effect of three decades of screening mammography on breast-cancer incidence.

Effect of screening and adjuvant therapy on mortality from breast cancer.

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.

Breast cancer adjuvant therapy: time to consider its time-dependent effects.

P304

e0157322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0157322

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27299729

http://www.w3.org/2001/XMLSchema#string

P932

4907475

http://www.w3.org/2001/XMLSchema#string